LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $300,000 | -16.0% | 2,294 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $357,000 | -11.4% | 2,344 | -42.3% | 0.00% | 0.0% |
| Q4 2020 | $403,000 | +14.5% | 4,059 | +9.4% | 0.00% | 0.0% |
| Q3 2020 | $352,000 | -4.3% | 3,710 | +12.6% | 0.00% | 0.0% |
| Q2 2020 | $368,000 | +43.8% | 3,294 | +33.7% | 0.00% | +100.0% |
| Q1 2020 | $256,000 | 0.0% | 2,463 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $256,000 | +14.3% | 2,463 | +9.1% | 0.00% | 0.0% |
| Q3 2019 | $224,000 | -44.0% | 2,258 | -35.8% | 0.00% | -50.0% |
| Q2 2019 | $400,000 | -3.1% | 3,517 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $413,000 | -98.9% | 3,298 | -98.8% | 0.00% | -98.9% |
| Q4 2018 | $38,018,000 | -21.4% | 280,174 | +59.0% | 0.18% | -4.6% |
| Q3 2018 | $48,377,000 | -34.3% | 176,247 | -50.4% | 0.19% | -40.5% |
| Q2 2018 | $73,675,000 | +36.9% | 355,626 | -9.5% | 0.33% | +45.5% |
| Q1 2018 | $53,801,000 | 0.0% | 392,932 | 0.0% | 0.22% | 0.0% |
| Q4 2017 | $53,801,000 | +26.3% | 392,932 | +25.6% | 0.22% | +19.8% |
| Q3 2017 | $42,599,000 | +54514.1% | 312,892 | +41955.4% | 0.19% | – |
| Q2 2017 | $78,000 | 0.0% | 744 | 0.0% | 0.00% | – |
| Q1 2017 | $78,000 | +11.4% | 744 | +6.6% | 0.00% | – |
| Q4 2016 | $70,000 | -1.4% | 698 | 0.0% | 0.00% | – |
| Q3 2016 | $71,000 | -10.1% | 698 | +4.5% | 0.00% | – |
| Q2 2016 | $79,000 | -9.2% | 668 | -19.2% | 0.00% | -100.0% |
| Q1 2016 | $87,000 | +19.2% | 827 | +20.0% | 0.00% | – |
| Q4 2015 | $73,000 | +25.9% | 689 | 0.0% | 0.00% | – |
| Q3 2015 | $58,000 | -9.4% | 689 | +6.0% | 0.00% | – |
| Q2 2015 | $64,000 | +39.1% | 650 | +7.8% | 0.00% | – |
| Q1 2015 | $46,000 | +43.8% | 603 | 0.0% | 0.00% | – |
| Q4 2014 | $32,000 | +45.5% | 603 | +27.5% | 0.00% | – |
| Q3 2014 | $22,000 | -31.2% | 473 | -9.6% | 0.00% | – |
| Q2 2014 | $32,000 | +146.2% | 523 | +164.1% | 0.00% | – |
| Q1 2014 | $13,000 | +30.0% | 198 | 0.0% | 0.00% | – |
| Q4 2013 | $10,000 | +25.0% | 198 | 0.0% | 0.00% | – |
| Q3 2013 | $8,000 | +14.3% | 198 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |